Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
102406 trials found · Page 174 of 5121
-
Could a diabetes drug curb alcohol cravings and save livers?
Disease control Recruiting nowBackground: People with alcohol use disorder (AUD) often develop metabolic alcohol-associated liver disease (MetALD). MetALD is a term for the heart, liver, obesity, and other issues that can accompany AUD. MetALD can be fatal. An approved weight management drug (Tirzepatide) ma…
Phase: PHASE2 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC
-
One shot showdown: can a new HPV vaccine match gardasil?
⭐️ VACCINE ⭐️ Not yet recruitingThe goal of this study is to compare the immune response of the single dose of the CERVAVAC vaccine with the single dose of Gardasil vaccine in girls/women aged 9 to 20 and boys aged 9 to 14 at 6 months, 12 months and 24 months post vaccination. The vaccine will be given randomly…
Phase: PHASE4 • Sponsor: International Agency for Research on Cancer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:07 UTC
-
New combo targets hard-to-treat breast cancer in early trial
Disease control Not yet recruitingThis is a randomized phase II study to evaluate the disease control rate (DCR) of patients with metastatic or locally advanced METHYLATED 06-methylguanine-DNA methyltransferase (MGMT) with triple-negative breast cancer (TNBC) treated with Temozolomide ± Olaparib. Patients will be…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 05, 2026 12:05 UTC
-
New hope for lung cancer patients who Can't take chemo
Disease control Recruiting nowThe purpose of this study is to measure efficacy and safety of osimertinib as induction therapy prior to curative intent RT and maintenance osimertinib in chemotherapy ineligible or refusal adult patients with Stage III, unresectable NSCLC with common EGFR mutations (exon 19 dele…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC
-
New score could guide ovarian cancer surgery timing
Disease control Not yet recruitingA prospective, international, multi-center, interventional trial of advanced epithelial ovarian cancer patients offered three cycles of neoadjuvant chemotherapy (NACT) and triaged with KELIM score. Patients with favorable score will undergo interval debulking surgery (IDS) follow…
Phase: NA • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated Jun 10, 2026 15:07 UTC
-
Spinal injury breakthrough: brain zaps may restore grip
Symptom relief Recruiting nowThe goal of this study is to restore the activities of late descending signals with a noninvasive stimulation approach in combination with hand motor training to improve hand function in persons with cervical SCI. The main question it aims to answer is if the inputs to late desce…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC
-
New combo therapy aims to rescue failing hearts without transplant
Disease control Not yet recruitingThe study will evaluate the impact of a combined device-drug strategy with Impella 5.5 with best practices and optimized GDMT on heart recovery outcomes in patients with decompensated heart failure and cardiogenic shock.
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated Jun 01, 2026 17:54 UTC
-
Could a simple injection stop pancreatic leaks after surgery?
Prevention Not yet recruitingThis study is a randomized, double-blind, placebo-controlled, multicenter phase III clinical trial designed to evaluate the efficacy and safety of octreotide microspheres in preventing pancreatic fistula after distal pancreatectomy.
Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Prevention
Last updated Jun 09, 2026 12:10 UTC
-
Skin stiffness test could predict diabetic foot ulcers before they start
Diagnosis Not yet recruitingDiabetes represents one of the major chronic diseases, with diabetic ulcers being a significant adverse prognosis. Approximately 80% of lower limb amputations are attributed to diabetic foot ulcers, which constitute a primary cause of patient disability and mortality, while also …
Sponsor: Peking University Third Hospital • Aim: Diagnosis
Last updated Jun 10, 2026 13:25 UTC
-
New hope for Hard-to-Treat breast cancer: Two-Drug combo shows promise
Disease control Recruiting nowThis study is looking at a new combination of two drugs-eribulin and anlotinib-for patients with HER2-negative advanced breast cancer. Participants in this study have already tried other treatments like T-DXd or SG, but their cancer has gotten worse, and there are currently no st…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
Can a school program stop child trafficking? new trial aims to find out
Prevention Not yet recruitingAlthough the exact scope of commercial sexual exploitation of children (CSEC) remains unknown, its significant negative physical and emotional consequences for children has been well-documented. The U.S. government recognized the need for improved CSEC prevention over two decades…
Phase: NA • Sponsor: University of New Hampshire • Aim: Prevention
Last updated Jun 03, 2026 12:06 UTC
-
New vaccine aims to cure hepatitis b – first human trial underway
Disease control Recruiting nowExisting nucleoside analogues (NAs) and interferon therapy for chronic hepatitis B (CHB) have limitations, including drug resistance, low HBsAg clearance rates, and irreversible immunosuppression. Therapeutic vaccines, by activating virus-specific T cells and B cells, hold promis…
Phase: PHASE1 • Sponsor: Jiyan Liu • Aim: Disease control
Last updated Jun 05, 2026 12:08 UTC
-
Tumor avatars could personalize chemo for kids with rare cancers
Disease control ENROLLING_BY_INVITATIONThis is a prospective, open-label, single-arm, single-center study designed to evaluate the feasibility of using patient-derived organoid drug sensitivity analysis to guide chemotherapy for pediatric patients with refractory and relapsed malignant soft tissue tumors. The primary …
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
Artificial cornea trial offers new hope for the blind
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled (1:1) non-inferiority clinical trial. A total of 54 subjects are scheduled to be enrolled at no fewer than 2 study sites in China. After providing written informed consent, all subjects will undergo screening assessments.…
Phase: NA • Sponsor: Shanghai Vision Science Engineer Medical Equipment Co., Ltd • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
New combo aims to stop leukemia from coming back
Disease control ENROLLING_BY_INVITATIONThis study intends to use a randomized controlled design to compare the MRD-negativw rate and related efficacy and safety of venetoclax combined with intermediate-dose cytarabine (IDAC) versus IDAC in the consolidation treatment of patients with AML after remission, providing hig…
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:29 UTC
-
Egyptian youth study aims to stop chronic diseases before they start
Prevention Not yet recruitingIn consistence of North Africa vision to decrease incidence of NCDs in different population type investigators decide to give more concerns to youth (young old) who are the main human power to build future. Recent data report non-communicable diseases (NCDs) are the current leadi…
Phase: NA • Sponsor: Deraya University • Aim: Prevention
Last updated Jun 08, 2026 13:10 UTC
-
New PET tracer could sharpen cancer diagnosis and staging
Diagnosis Recruiting nowThis project utilizes LRRC15-specific targeted PET radiotracers to perform PET/MR or PET/CT imaging on healthy volunteers and patients with clinically suspected or confirmed malignancies characterized by high LRRC15 expression-including pancreatic cancer, breast cancer, lung canc…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Diagnosis
Last updated Jun 10, 2026 13:29 UTC
-
New triple therapy hopes to outsmart tough esophageal cancer
Disease control Not yet recruitingEsophageal squamous cell carcinoma (ESCC) is a common malignant tumor worldwide, with particularly high incidence in East Asian regions such as China, and is associated with poor patient prognosis. In recent years, immune checkpoint inhibitors (e.g., anti-PD-1/PD-L1 antibodies) c…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 09, 2026 12:08 UTC
-
New hope for tough pancreatic cancer: targeted drug trial launches
Disease control Not yet recruitingThis is a multicenter, prospective, open-label Phase II clinical study designed to evaluate the efficacy and safety of sacituzumab govitecan monotherapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma who have failed at least one prior line of the…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
New drug may extend remission in tough lung cancer
Disease control Not yet recruitingThis study aims to evaluate the efficacy and safety of adebrelimab consolidation therapy after progression-free response of concurrent chemoradiotherapy in patients with limited-stage small cell lung cancer. This study plans to enroll patients with untreated limited-stage small c…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 10, 2026 13:26 UTC